Receptors for Aggregated IgG on Mouse Lymphocytes: Their Presence on Thymocytes, Thymus-derived, and Bone Marrow-derived Lymphocytes
Overview
General Medicine
Authors
Affiliations
An autoradiographic binding assay employing (125)I-labeled heat-aggregated mouse IgG2b myeloma protein (MOPC 141) was used to demonstrate receptors for IgG on 20-45% of Balb/c thymocytes and on 70-80% of splenocytes. Binding could also be shown with heat or BDB aggregates of another IgG2b (MOPC 195), with IgG1 and with human gamma-globulin, but not with aggregated chicken gamma-globulin, IgA, BSA, nor with aggregated Fab fragments of IgG2b. Optimum binding was obtained at 37 degrees C. Detection of binding was dependent upon aggregate size with complexes of more than 100 IgG molecules being optimal, aggregates of 6-25 detecting splenocytes but not thymocytes, and aggregates of less than 6 binding to a negligible extent. Comparison of grain counts on various cell types showed mastocytoma cells (P815) and macrophages averaging 40-50 grains/cell/day, allogeneically activated thymocytes 20-30, splenocytes 2-3, L5178 lymphoma cells 1, and positive thymocytes 0.6 grains/cell/day. Double labeling experiments for surface Ig, theta-antigen, and agg IgG receptor on mouse spleen cells indicated that a relatively high density of receptor was present on about 80% of B cells, 30% of T cells, and 60% of SIg(-), theta(-), null cells.
FcγRIIB expressed on CD8 T cells limits responsiveness to PD-1 checkpoint inhibition in cancer.
Bennion K, Tariq M, Wyatt M, Duneton C, Baecher K, Paulos C Sci Transl Med. 2023; 15(710):eadd1868.
PMID: 37611081 PMC: 11325091. DOI: 10.1126/scitranslmed.add1868.
FcγRIIB is a T cell checkpoint in antitumor immunity.
Farley C, Morris A, Tariq M, Bennion K, Potdar S, Kudchadkar R JCI Insight. 2021; 6(4).
PMID: 33616086 PMC: 7934918. DOI: 10.1172/jci.insight.135623.
Morris A, Farley C, Pinelli D, Adams L, Cragg M, Boss J Immunity. 2020; 52(1):136-150.e6.
PMID: 31940267 PMC: 7326381. DOI: 10.1016/j.immuni.2019.12.006.
The Neonatal Fc Receptor (FcRn): A Misnomer?.
Pyzik M, Sand K, Hubbard J, Andersen J, Sandlie I, Blumberg R Front Immunol. 2019; 10:1540.
PMID: 31354709 PMC: 6636548. DOI: 10.3389/fimmu.2019.01540.
Rous-Whipple Award lecture. The biology and pathology of lymphocyte Fc receptors.
Lynch R Am J Pathol. 1998; 152(3):631-9.
PMID: 9502402 PMC: 1858407.